abstract |
A compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein m, n, p, q, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are defined herein As defined in). Also disclosed are methods for making the compounds and methods for using the compounds in the treatment of diseases associated with P2X7 purine receptors. |